1.Report from Working Group on Postgraduate Medical School and Speciality Training. With a Special Emphasis on Clinical Course in Postgraduate Medical School.
Fumimaro TAKAKU ; Tadahiko KOZU ; Emiko ADACHI ; Kiyohiko HATAKE ; Masahiko HATAO ; Kunitake HIRASHIMA ; Takanobu IMANAKA ; Tetsuo ISHII ; Yasunori KANAZAWA ; Kei MATSUEDA
Medical Education 1996;27(1):3-8
Discussions on the postgraduate medical school and the speciality training course after graduation had been conducted 2 times in 1994 among the members of the working group on postgraduate medical school and speciality training in Japanese Society for Medical Education. Results of the discussion are reported in this paper as a proposal for the improvement of the present state of education and training in the postgraduate medical schools in our country. In this report, several important proposals which need further discussions such as the shortening the clinical course in postgraduate medical school to 3 years from present 4 years and necessity of establishing the obligatory course for training the basic technology for life science research are presented. It is mandatory to have full time teaching staff as well as exclusive space for postgraduate course in each school to improve the of education of postgraduate medical schools.
2.A Case Report on Effect of Asenapine Sublingual Tablets on Intractable Nausea in a Patient of Terminal Malignant Lymphoma with Diabetes Who Cannot Take Oral Medicine
Hiroyuki WATANABE ; Kazuyuki NAKAMURA ; Ayumi ISHIKAWA ; Jinwoo LEE ; Yasunori ADACHI ; Toshitaka NABESHIMA ; Yoji SUGIURA
Palliative Care Research 2021;16(2):133-138
Introduction: We report a case of intractable nausea of a terminal malignant lymphoma patient with diabetes, which improved by sublingual administration of asenapine. Case: A 78-year-old man suffering from diffuse large B-cell lymphoma with diabetes presented intractable nausea and vomiting. Those symptoms were thought to be due to masses and nodules in the right frontal lobe and the cerebellum, and/or due to edema in the peripheral brain parenchyma. Because it was difficult to take medicines orally, we selected injections to control those symptoms. However, the combination of metoclopramide, haloperidol, and hydroxyzine injections failed to relieve nausea. Olanzapine is effective against nausea but is contraindicated for diabetic patients, so asenapine, one of the multi-acting receptor-targeted antipsychotics the same as olanzapine, was expected alternatively. The patient was administrated asenapine sublingually 5mg once a day before bedtime. This administration of asenapine remarkably improved his nausea. Discussion: Sublingual asenapine dose may be an effective therapeutic option for intractable nausea.
Result Analysis
Print
Save
E-mail